Drotrecogin alfa (activated): From Bench to practical use at the bedsideDHAINAUT, Jean-François.The American journal of surgery. 2002, Vol 184, Num 6A, issn 0002-9610, 51 p., SUPSerial Issue

L'information du patient en réanimation = Information of patient in reanimationLIENHART, André; DHAINAUT, Jean-Francois.Annales françaises d'anesthésie et de réanimation. 2001, Vol 20, Num 7, issn 0750-7658, p. fi118Article

Coagulation et sepsis : Choc septique = Coagulation and sepsisDHAINAUT, Jean-Francois; MARIN, Nathalie.MT. Médecine thérapeutique. 2001, Vol 7, Num 4, pp 294-298, issn 1264-6520Article

Identifying responsive populations in sepsisDHAINAUT, Jean-François; ABRAHAM, Edward.Clinical infectious diseases. 2005, Vol 41, issn 1058-4838, 127 p., SUP7Conference Proceedings

Activated protein C versus protein C in severe sepsisYAN, S. Betty; DHAINAUT, Jean-Francois.Critical care medicine. 2001, Vol 29, Num 7, pp S69-S74, issn 0090-3493, SUPConference Paper

Myocardial dysfunction in sepsisDHAINAUT, Jean-Francois; CARIOU, Alain; LAURENT, Ivan et al.Sepsis (Boston). 2001, Vol 4, Num 2, pp 89-97, issn 1385-0229Article

Protéine C activée et choc septique = Activated protein C and septic shockDHAINAUT, Jean-Francois; MARIN, Nathalie; CHARPENTIER, Lulien et al.La Revue du praticien (Paris). 2003, Vol 53, Num 1, pp 5-6, issn 0035-2640, 2 p.Article

Pharmacogenetic analysis of clinically relevant genetic polymorphismsMCLEOD, Howard L.Clinical infectious diseases. 2005, Vol 41, pp S449-S452, issn 1058-4838, SUP7Conference Paper

Conclusions: drotrecogin alfa (activated): from bench to practical use at the bedsideMAKI, Dennis G.The American journal of surgery. 2002, Vol 184, Num 6A, pp 47-49, issn 0002-9610, 3 p., SUPArticle

Human leukocyte antigen class II haplotypes that protect against or predispose to streptococcal toxic shockLLEWELYN, Martin.Clinical infectious diseases. 2005, Vol 41, pp S445-S448, issn 1058-4838, SUP7Conference Paper

Management of patients with severe sepsis, treated by drotrecogin alfa (activated)LATERRE, Pierre-Francois; HEISELMAN, Darell.The American journal of surgery. 2002, Vol 184, Num 6A, pp 39-46, issn 0002-9610, 8 p., SUPArticle

Départements hospitalo-universitaires: dynamiser les hôpitaux universitaires ! = Energize the university hospitalDHAINAUT, Jean-François; HUMBERT, Marc; UZAN, Serge et al.La Presse médicale (1983). 2012, Vol 41, Num 5, pp 451-452, issn 0755-4982, 2 p.Article

Alterations in cell signaling in sepsisABRAHAM, Edward.Clinical infectious diseases. 2005, Vol 41, pp S459-S464, issn 1058-4838, SUP7Conference Paper

Epidemiology of sepsis : Race, sex, and chronic alcohol abuseMOSS, Marc.Clinical infectious diseases. 2005, Vol 41, pp S490-S497, issn 1058-4838, SUP7Conference Paper

Lipopolysaccharide : An endotoxin or an exogenous hormone?MARSHALL, John C.Clinical infectious diseases. 2005, Vol 41, pp S470-S480, issn 1058-4838, SUP7Conference Paper

Protein C pathways: Beside to benchDHAINAUT, Jean-François; AIRD, William; ESMON, Charles et al.Critical care medicine. 2004, Vol 32, Num 5, issn 0090-3493, 154 p., SUPConference Proceedings

Protein C/activated protein C pathway: Overview of clinical trial results in severe sepsisDHAINAUT, Jean-Francois; YAN, S. Betty; CLAESSENS, Yann-Erick et al.Critical care medicine. 2004, Vol 32, Num 5, pp S194-S201, issn 0090-3493, SUPConference Paper

Transforming growth factor-β: A mediator of cell regulation in acute respiratory distress syndromeDHAINAUT, Jean-Francois; CHARPENTIER, Julien; CHICHE, Jean-Daniel et al.Critical care medicine. 2003, Vol 31, Num 4, pp S258-S264, issn 0090-3493, SUPConference Paper

Underlying disorders and their impact on the host response to infectionDHAINAUT, Jean-Francois; CLAESSENS, Yann-Erick; JANES, Jonathan et al.Clinical infectious diseases. 2005, Vol 41, pp S481-S489, issn 1058-4838, SUP7Conference Paper

Anticoagulant therapy in acute lung injuryLATERRE, Pierre-Francois; WITTEBOLE, Xavier; DHAINAUT, Jean-Francois et al.Critical care medicine. 2003, Vol 31, Num 4, pp S329-S336, issn 0090-3493, SUPConference Paper

Selecting patients with severe sepsis for drotrecogin alfa (activated) therapySOLLET, Jean-Pierre; GARBER, Gary E.The American journal of surgery. 2002, Vol 184, Num 6A, pp 11-18, issn 0002-9610, 8 p., SUPArticle

Platelet factor 4 modulation of the thrombomodulin-protein C systemSLUNGAARD, Arne.Critical care medicine. 2004, Vol 32, Num 5, pp S331-S335, issn 0090-3493, SUPConference Paper

Protease-activated receptor signaling in the regulation of inflammationRUF, Wolfram.Critical care medicine. 2004, Vol 32, Num 5, pp S287-S292, issn 0090-3493, SUPConference Paper

Acute lung injury: understanding the mechanisms of injury and repairDHAINAUT, Jean-François; BROWER, Roy G; RUSSELL, James A et al.Critical care medicine. 2003, Vol 31, Num 4, issn 0090-3493, 165 p., SUPConference Proceedings

Endpoints in sepsis trials: More than just 28-day mortality?VINCENT, Jean-Louis.Critical care medicine. 2004, Vol 32, Num 5, pp S209-S213, issn 0090-3493, SUPConference Paper